These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37004778)

  • 1. AZ2158 is a more potent formyl peptide receptor 1 inhibitor than the commonly used peptide antagonists in abolishing neutrophil chemotaxis.
    Forsman H; Wu Y; Mårtensson J; Björkman L; Granberg KL; Dahlgren C; Sundqvist M
    Biochem Pharmacol; 2023 May; 211():115529. PubMed ID: 37004778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
    Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
    J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1.
    Yang SC; Chung PJ; Ho CM; Kuo CY; Hung MF; Huang YT; Chang WY; Chang YW; Chan KH; Hwang TL
    J Immunol; 2013 Jun; 190(12):6511-9. PubMed ID: 23670191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
    Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
    Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
    Cevik-Aras H; Kalderén C; Jenmalm Jensen A; Oprea T; Dahlgren C; Forsman H
    Biochem Pharmacol; 2012 Jun; 83(12):1655-62. PubMed ID: 22410002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Larixol is not an inhibitor of Gα
    Björkman L; Forsman H; Bergqvist L; Dahlgren C; Sundqvist M
    Biochem Pharmacol; 2024 Feb; 220():115995. PubMed ID: 38151076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Determinants in the
    Viklund M; Fredriksson J; Holdfeldt A; Lind S; Franzyk H; Dahlgren C; Sundqvist M; Forsman H
    J Immunol; 2022 Apr; 208(7):1632-1641. PubMed ID: 35321878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
    Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL
    Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randialic acid B and tomentosolic acid block formyl peptide receptor 1 in human neutrophils and attenuate psoriasis-like inflammation in vivo.
    Korinek M; Hsieh PS; Chen YL; Hsieh PW; Chang SH; Wu YH; Hwang TL
    Biochem Pharmacol; 2021 Aug; 190():114596. PubMed ID: 33964283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role for endogenous mitochondrial formylated peptide-driven formyl peptide receptor 1 signalling in acute respiratory distress syndrome.
    Dorward DA; Lucas CD; Doherty MK; Chapman GB; Scholefield EJ; Conway Morris A; Felton JM; Kipari T; Humphries DC; Robb CT; Simpson AJ; Whitfield PD; Haslett C; Dhaliwal K; Rossi AG
    Thorax; 2017 Oct; 72(10):928-936. PubMed ID: 28469031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
    Kirpotina LN; Schepetkin IA; Khlebnikov AI; Ruban OI; Ge Y; Ye RD; Kominsky DJ; Quinn MT
    Biochem Pharmacol; 2017 Oct; 142():120-132. PubMed ID: 28690139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead.
    Winther M; Gabl M; Welin A; Dahlgren C; Forsman H
    FEBS Lett; 2015 Jul; 589(15):1832-9. PubMed ID: 26071379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis Inhibitory Protein of S. aureus.
    Boer JC; Domanska UM; Timmer-Bosscha H; Boer IG; de Haas CJ; Joseph JV; Kruyt FA; de Vries EG; den Dunnen WF; van Strijp JA; Walenkamp AM
    Br J Cancer; 2013 Feb; 108(3):587-96. PubMed ID: 23322202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Cheng N; Ye RD; Quinn MT
    Biochem Pharmacol; 2014 Dec; 92(4):627-41. PubMed ID: 25450672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria.
    Dahlgren C; Gabl M; Holdfeldt A; Winther M; Forsman H
    Biochem Pharmacol; 2016 Aug; 114():22-39. PubMed ID: 27131862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Garcinia Multiflora Inhibits FPR1-Mediated Neutrophil Activation and Protects Against Acute Lung Injury.
    Tsai YF; Yang SC; Chang WY; Chen JJ; Chen CY; Chang SH; Hwang TL
    Cell Physiol Biochem; 2018; 51(6):2776-2793. PubMed ID: 30562761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Two Formyl Peptide Receptors Differently Regulate GPR84-Mediated Neutrophil NADPH Oxidase Activity.
    Mårtensson J; Sundqvist M; Manandhar A; Ieremias L; Zhang L; Ulven T; Xie X; Björkman L; Forsman H
    J Innate Immun; 2021; 13(4):242-256. PubMed ID: 33789297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1.
    Yang SC; Chang SH; Hsieh PW; Huang YT; Ho CM; Tsai YF; Hwang TL
    Free Radic Biol Med; 2017 May; 106():254-269. PubMed ID: 28232203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.
    Kretschmer D; Rautenberg M; Linke D; Peschel A
    J Leukoc Biol; 2015 Apr; 97(4):689-97. PubMed ID: 25724390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation.
    Dorward DA; Lucas CD; Chapman GB; Haslett C; Dhaliwal K; Rossi AG
    Am J Pathol; 2015 May; 185(5):1172-84. PubMed ID: 25791526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.